The Wall Street Journal (4/29, Subscription Publication) reports the Centers for Medicare and Medicaid Services is considering a rule which would mandate that drug companies show the list prices of prescription medications while advertising the drugs on television. Although the proposed rule is largely supported by consumers, the pharmaceutical industry opposes it, partly because list prices often do not reflect what consumers typically pay for the drugs after rebates and insurance.
Related Links:
— “Should Drug Prices Be Disclosed in Ads Targeted Directly to Consumers?,, April 29, 2019